 |
 |
|
Browse all recently published reports
July 1, 2008
A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market... more>>
June 26, 2008
Because of its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy... more>>
June 25, 2008
China's Renal Cell Carcinoma Drug Market Will Grow More Than Five-Fold by 2012... more>>
View all press releases
|
|
|
 |
|
|
Introducing Pharmaview, the most comprehensive view of the pharmaceutical industry.
Pharmaview covers all the angles of analysis and forecasts from both a corporate and therapeutic standpoint.
Click here to learn more.
|
|
 |
 |
|
Opportunities for Emerging Disease-Modifying Therapies in Multiple Sclerosis
This webinar, based on our Treatment Algorithms in Multiple Sclerosis report, focuses on disease-modifying biologic drugs that gain the greatest patient shares in the earliest lines of therapy and key factors driving therapy choice among physicians.
Click here to access a playback of this event.
|
|
